Bowel Cancer UK have launched a new report titled: 'Finding the key to the cures: A plan to end bowel cancer by 2050'. The report’s aim is to draw attention to the significant research gaps that exist around bowel cancer (also known as colorectal cancer or CRC).
CRC is the most common type of digestive cancer in Europe with 68 cases per 100,000 population. In 2012, 342,137 people were diagnosed with CRC throughout Europe, accounting for 14.3% of all cancers diagnoses across the continent. The report outlined that, within the UK, 332,000 lives will be lost to the disease between now and 2035. Despite how many lives will be lost, CRC is often very treatable if it is diagnosed early.
In publishing the report, Bowel Cancer UK are looking to accelerate the current state of CRC support and funding, highlighting the importance of early diagnosis and improved treatment to ensure that more people are able to survive the cancer. The charity states that strategic investment in high quality research is urgently required, as well as shared learning to help improve the collaborative efforts of a variety of organisations that all share the same goal of improving CRC survival.
Bowel Cancer UK therefore call on healthcare professionals, patients and organisation to be catalysts for changes to enhance the lives of current and future CRC patients. Taking part in research, sharing awareness-raising stories and taking action in campaigns to facilitate early diagnosis and access to treatment are all methods outlined within the report that can help facilitate this change.
About Bowel Cancer UK
Bowel Cancer UK is the UK’s leading CRC charity, determined to save lives and improve the quality of life for all those affected by CRC. The charity not only support and enable research through their campaigning, but also provide expert information, education services and fundraising.